XTMAB-16

DB18380InvestigationalProtein Based Therapies

XTMAB-16 is a monoclonal antibody directed against tumour necrosis factor-alpha (TNFα).

Mechanism: Pharmacologically active on Tumor necrosis factor
Curator reviewed

Resolves to

Targets

What you can answer from here — as of July 09, 2026

1Protein targetEach mapped to UniProt, with action and pharmacological action

Listed above

4Clinical trialsPhase, status and sponsor resolved per trial

1+ReferenceStructured and connected to the statements they support

Which drugs share a target with XTMAB-16, and which of those have an active Phase 3 trial?

Create a free account or log in to explore the full data card.